Northern Trust’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Northern Trust’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-822,026	Closed	-$5.48M	–	4574
2023 Q3	$5.48M	Buy	822,026 +20,832	+3%	+$173K	﹤0.01%	2388
2023 Q2	$7.26M	Buy	801,194 +44,938	+6%	+$396K	﹤0.01%	2273
2023 Q1	$5.5M	Buy	756,256 +31,945	+4%	+$237K	﹤0.01%	2409
2022 Q4	$5.28M	Buy	724,311 +81,502	+13%	+$605K	﹤0.01%	2452
2022 Q3	$4.97M	Sell	642,809 -2,014	-0.3%	-$17.1K	﹤0.01%	2485
2022 Q2	$4.39M	Buy	644,823 +507,941	+371%	+$3.89M	﹤0.01%	2605
2022 Q1	$1.09M	Sell	136,882 -2,436	-2%	-$15.5K	﹤0.01%	3379
2021 Q4	$780K	Buy	139,318 +9,433	+7%	+$70.8K	﹤0.01%	3634
2021 Q3	$999K	Buy	+129,885	New	+$1.18M	﹤0.01%	3555

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Northern Trust's PNT Position: Q4 2023 in Review

Northern Trust sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 822,026 shares — an estimated $5.48M sold.

Northern Trust first reported a position in PNT in Q3 2021 and held it in 9 quarters. The position peaked at $7.26M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Northern Trust reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Northern Trust sold 822,026 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.48M.
Northern Trust first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Northern Trust's POINT Biopharma Global Inc. Common Stock position peaked at $7.26M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.